Insilico Medicine, a clinical-stage company leveraging generative artificial intelligence (AI) for drug discovery and development, has announced promising results for its novel drug, ISM5411, aimed at treating Inflammatory Bowel Disease (IBD). This gut-restricted and PHD-specific inhibitor was
Artificial Intelligence (AI) is making significant strides in various fields, and drug development is no exception. While AI's applications in text generation, facial recognition, and autonomous driving are well-known, its potential in drug discovery is equally transformative, promising to
The ability of Generative Pre-trained Transformer 4 (GPT-4) to effectively analyze medical notes in multiple languages has garnered significant interest within the medical and technology communities. A recently published comprehensive evaluation study in Lancet Digital Health by a consortium of
The role of artificial intelligence (AI) in drug discovery and development has been a topic of increasing interest and debate, with many experts heralding its promise to transform the process by reducing time and costs significantly. Amid the excitement, however, there remain substantial challenges
The advancements in artificial intelligence (AI) techniques, particularly in the analysis of medical imagery to enhance tumor detection in positron emission tomography (PET) and computed tomography (CT) scans, are set to revolutionize the field. These advancements are especially relevant due to the
The pharmaceutical industry is undergoing a significant transformation driven by artificial intelligence (AI). This revolution is not just about improving processes but reshaping disease treatment and care delivery. Early adopters of AI in this sector are experiencing substantial gains,
